Wells FR - Search Results

1

Decreased ferritin levels in brain in Parkinson's disease.

Dexter DT, Carayon A, Vidailhet M, Ruberg M, Agid F, Agid Y, Lees AJ, Wells FR, Jenner P, Marsden CD. Dexter DT, et al. Among authors: wells fr. J Neurochem. 1990 Jul;55(1):16-20. doi: 10.1111/j.1471-4159.1990.tb08814.x. J Neurochem. 1990. PMID: 2355217

2

Alpha-tocopherol levels in brain are not altered in Parkinson's disease.

Dexter DT, Ward RJ, Wells FR, Daniel SE, Lees AJ, Peters TJ, Jenner P, Marsden CD. Dexter DT, et al. Among authors: wells fr. Ann Neurol. 1992 Oct;32(4):591-3. doi: 10.1002/ana.410320420. Ann Neurol. 1992. PMID: 1456747

3

Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia.

Dexter DT, Carayon A, Javoy-Agid F, Agid Y, Wells FR, Daniel SE, Lees AJ, Jenner P, Marsden CD. Dexter DT, et al. Among authors: wells fr. Brain. 1991 Aug;114 ( Pt 4):1953-75. doi: 10.1093/brain/114.4.1953. Brain. 1991. PMID: 1832073

4

Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease.

Dexter DT, Wells FR, Lees AJ, Agid F, Agid Y, Jenner P, Marsden CD. Dexter DT, et al. Among authors: wells fr. J Neurochem. 1989 Jun;52(6):1830-6. doi: 10.1111/j.1471-4159.1989.tb07264.x. J Neurochem. 1989. PMID: 2723638

5

A selective increase in particulate superoxide dismutase activity in parkinsonian substantia nigra.

Saggu H, Cooksey J, Dexter D, Wells FR, Lees A, Jenner P, Marsden CD. Saggu H, et al. Among authors: wells fr. J Neurochem. 1989 Sep;53(3):692-7. doi: 10.1111/j.1471-4159.1989.tb11759.x. J Neurochem. 1989. PMID: 2760616

6

Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease.

Dexter DT, Carter CJ, Wells FR, Javoy-Agid F, Agid Y, Lees A, Jenner P, Marsden CD. Dexter DT, et al. Among authors: wells fr. J Neurochem. 1989 Feb;52(2):381-9. doi: 10.1111/j.1471-4159.1989.tb09133.x. J Neurochem. 1989. PMID: 2911023

7

Altered muscarinic and nicotinic receptor densities in cortical and subcortical brain regions in Parkinson's disease.

Lange KW, Wells FR, Jenner P, Marsden CD. Lange KW, et al. Among authors: wells fr. J Neurochem. 1993 Jan;60(1):197-203. doi: 10.1111/j.1471-4159.1993.tb05838.x. J Neurochem. 1993. PMID: 8417140 Free article.

8

Cortical muscarinic receptors in demented patients with Alzheimer's disease or Parkinson's disease.

Lange KW, Wells FR, Rossor MN, Jenner P, Marsden CD. Lange KW, et al. Among authors: wells fr. Br J Pharmacol. 1989 Dec;98 Suppl:817P. Br J Pharmacol. 1989. PMID: 2611524 Free article. No abstract available.

9

Increased levels of lipid hydroperoxides in the parkinsonian substantia nigra: an HPLC and ESR study.

Dexter DT, Holley AE, Flitter WD, Slater TF, Wells FR, Daniel SE, Lees AJ, Jenner P, Marsden CD. Dexter DT, et al. Among authors: wells fr. Mov Disord. 1994 Jan;9(1):92-7. doi: 10.1002/mds.870090115. Mov Disord. 1994. PMID: 8139611

10

Indices of oxidative stress and mitochondrial function in individuals with incidental Lewy body disease.

Dexter DT, Sian J, Rose S, Hindmarsh JG, Mann VM, Cooper JM, Wells FR, Daniel SE, Lees AJ, Schapira AH, et al. Dexter DT, et al. Among authors: wells fr. Ann Neurol. 1994 Jan;35(1):38-44. doi: 10.1002/ana.410350107. Ann Neurol. 1994. PMID: 8285590

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

29 results

Search Page

Filters